Company: TVRD
Filing Date: 2025-03-24
Form Type: 8-K
Source: 0001104659-25-027233
Chunk: 12

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-03-24
Form: 8-K
Item: Item 8.01
Chunk 12
---
 AND RELATED MATTERS. Stockholders are and will be able to obtain free copies of
the proxy statement, prospectus and other documents filed by Cara with the SEC (when they become available) through the
website maintained by the SEC at www. sec. gov. In addition, stockholders are or will be able to obtain free copies of the
proxy statement, prospectus and other documents filed by Cara with the SEC by contacting Investor Relations by email at investor@caratherapeutics. com.
Stockholders are urged to read the proxy statement, prospectus and the other relevant materials when they become available before
making any voting or investment decision with respect to the proposed transaction.

Participants in the Solicitation

Cara and Tvardi, and each of their respective
directors and executive officers and certain of their other members of management and employees, may be deemed to be participants in the
solicitation of proxies in connection with the proposed transaction. Information about Cara’s directors and executive officers,
consisting of Helen M. Boudreau, Jeffrey L. Ives, Ph. D., Christopher Posner, Susan Shiff, Ph. D., Martin Vogelbaum, Lisa von Moltke, M. D.,
Ryan Maynard and Scott Terrillion, including a description of their interests in Cara, by security holdings or otherwise, can be
found under the captions “ Cara’s Executive and Director Compensation” and “ Principal Stockholders of Cara”
contained in the proxy statement/prospectus. To the extent that Cara’s directors and executive officers and their respective
affiliates have acquired or disposed of security holdings since the applicable “as of” date disclosed in the proxy statement/prospectus,
such transactions have been or will be reflected on Statements of Change in Beneficial Ownership on Form 4 filed with the SEC. Additional
information regarding the persons who may be deemed participants in the proxy solicitation, including the information about the directors
and executive officers of Tvardi, and a description of their direct and indirect interests, by security holdings or otherwise, are also
included in the proxy statement/prospectus. Investors should read the registration statement, proxy statement/prospectus and the other
relevant materials when they become available before making any voting or investment decision with respect to the proposed transaction.
These documents can be obtained free of charge from the sources indicated above.

No Offer or Solicitation

This Current Report on Form 8-K shall not constitute
an offer to sell or the solicitation of an offer to sell or the